Foshan Flying Medical Products Co., Ltd. FDA Warning (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on August 01, 2017
Executive Summary
The FDA issued a warning letter to Foshan Flying Medical Products Co., Ltd. on August 01, 2017 citing cgmp violations. The letter was issued by Center for Drug Evaluation and Research.
Detailed Analysis
False Claims and Regulatory Violations
The FDA identified regulatory violations in Foshan Flying Medical Products Co., Ltd.'s operations or product claims.
Potential Health Risks
Consumers should be aware of potential risks associated with products from Foshan Flying Medical Products Co., Ltd..
Regulatory Context
batch numbers for raw materials used in the manufacturing process; and
information on equipment and methods used to(b)(4)active ingredients (e.g.,(b)(4);(b)(4)).
revised master records for each of your drug products that fully document the manufacturing operation, including one executed batch production and control record for each product; and
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Foshan Flying Medical Products Co., Ltd.?
- The FDA issued a warning letter citing cgmp violations related to their products or manufacturing practices.
- Are Foshan Flying Medical Products Co., Ltd. products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have cgmp violations that may affect product safety.
- What should I do if I've used Foshan Flying Medical Products Co., Ltd. products?
- If you have used products from Foshan Flying Medical Products Co., Ltd. and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter